EI
XLRN

Ellevest Inc’s Acceleron Pharma XLRN Stock Holding History

Ellevest Inc’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-146
Closed -$25K – 1778
2021
Q3 		$25K Sell
146
-59
-29% -$7.72K ﹤0.01% 623
2021
Q2 		$26K Sell
205
-15
-7% -$1.89K ﹤0.01% 599
2021
Q1 		$30K Buy
220
+69
+46% +$8.91K ﹤0.01% 581
2020
Q4 		$19K Buy
151
+80
+113% +$9.38K ﹤0.01% 651
2020
Q3 		$8K Buy
71
+14
+25% +$1.39K ﹤0.01% 697
2020
Q2 		$5K Sell
57
-27
-32% -$2.6K ﹤0.01% 765
2020
Q1 		$8K Buy
84
+45
+115% +$3.5K ﹤0.01% 597
2019
Q4 		$2K Buy
39
+26
+200% +$1.19K ﹤0.01% 710
2019
Q3 		$1K Buy
+13
New +$564 ﹤0.01% 484

Ellevest Inc's XLRN Position: Q4 2021 in Review

Ellevest Inc sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 146 shares — an estimated $25K sold.

Ellevest Inc first reported a position in XLRN in Q3 2019 and held it in 9 quarters. The position peaked at $30K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Ellevest Inc reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Ellevest Inc sold 146 Acceleron Pharma shares in Q4 2021, an estimated $25K.
  • Ellevest Inc first reported a position in Acceleron Pharma in Q3 2019 and held it in 9 quarters.
  • Ellevest Inc's Acceleron Pharma position peaked at $30K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.